Iron, Iodine, Folic Acid, Copper and Riboflavin: study protocols
6 study groups took Iron together with Iodine, Folic Acid, Copper and Riboflavin. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Iron
6 study groups in 4 studies say how much Iron participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 5 mg to 10 mg and 25 mg to 50 mg and 50 mg to 100 mg, 33% of 6 study groups each.
| Daily dose | Study groups |
|---|---|
| 5 mg to 10 mg | 2 |
| 10 mg to 25 mg | 0 |
| 25 mg to 50 mg | 2 |
| 50 mg to 100 mg | 2 |
Dose per serving from research: Iodine
6 study groups in 4 studies say how much Iodine participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 100 mcg to 250 mcg and 250 mcg to 500 mcg, 33% of 6 study groups each.
| Daily dose | Study groups |
|---|---|
| 25 mcg or less | 1 |
| 25 mcg to 50 mcg | 0 |
| 50 mcg to 100 mcg | 1 |
| 100 mcg to 250 mcg | 2 |
| 250 mcg to 500 mcg | 2 |
Dose per serving from research: Folic Acid
6 study groups in 4 studies say how much Folic Acid participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 250 mcg to 500 mcg, 83% of 6 study groups.
| Daily dose | Study groups |
|---|---|
| 100 mcg to 250 mcg | 1 |
| 250 mcg to 500 mcg | 5 |
Dose per serving from research: Copper
6 study groups in 4 studies say how much Copper participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 mg to 2.5 mg and 2.5 mg to 5 mg, 33% of 6 study groups each.
| Daily dose | Study groups |
|---|---|
| 250 mcg to 500 mcg | 1 |
| 500 mcg to 1 mg | 1 |
| 1 mg to 2.5 mg | 2 |
| 2.5 mg to 5 mg | 2 |
Dose per serving from research: Riboflavin
6 study groups in 4 studies say how much Riboflavin participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 mg to 2.5 mg and 2.5 mg to 5 mg, 33% of 6 study groups each.
| Daily dose | Study groups |
|---|---|
| 250 mcg or less | 1 |
| 250 mcg to 500 mcg | 1 |
| 500 mcg to 1 mg | 0 |
| 1 mg to 2.5 mg | 2 |
| 2.5 mg to 5 mg | 2 |
Commonly used together
6 of 6 study groups took Iron, Iodine, Folic Acid, Copper and Riboflavin with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Niacin | 6 |
| Selenium | 6 |
| Vitamin A | 6 |
| Zinc | 6 |
| Vitamin C | 5 |
| Vitamin D | 5 |
| Vitamin E | 5 |
| Vitamin B6 | 4 |
6 study groups
| Study | |||||||
|---|---|---|---|---|---|---|---|
| Predictors of adherence to micronutrient supplementation before and during pregnancy in Vietnam 2017 · MM (multiple micronutrients) preconception group · Women of reproductive age in Vietnam intending to become pregnant | 8.57 mg | 21.4 mcg | 400 mcg | 286 mcg | 200 mcg | 54 weeks | 1,469 |
| Assessing the adherence and acceptability to iron and folic acid compared with multiple micronutrient supplements during pregnancy: a cluster-randomized noninferiority trial in Cambodia 2025 · MMS-180 · Healthy pregnant individuals aged 18–45 years, in the first 14 weeks of a low-risk singleton pregnancy | 30 mg | 150 mcg | 400 mcg | 2 mg | 1.4 mg | 180 days | 516 |
| Assessing the adherence and acceptability to iron and folic acid compared with multiple micronutrient supplements during pregnancy: a cluster-randomized noninferiority trial in Cambodia 2025 · MMS-90 · Healthy pregnant individuals aged 18–45 years, in the first 14 weeks of a low-risk singleton pregnancy | 30 mg | 150 mcg | 400 mcg | 2 mg | 1.4 mg | 180 days | 515 |
| Iron status and inherited haemoglobin disorders modify the effects of micronutrient powders on linear growth and morbidity among young Lao children in a double-blind randomised trial 2019 · MNP group · Children aged 6–23 months in rural Lao PDR; young children, including children with anaemia and inherited haemoglobin disorders | 6 mg | 90 mcg | 150 mcg | 560 mcg | 500 mcg | 36 weeks | 852 |
| mRNA Levels of Placental Iron and Zinc Transporter Genes Are Upregulated in Gambian Women with Low Iron and Zinc Status 2017 · MMN group · Pregnant women aged 18–45 years with singleton pregnancies under 20 weeks in rural Gambia | 60 mg | 300 mcg | 400 mcg | 4 mg | 2.8 mg | 184 days | 75 |
| mRNA Levels of Placental Iron and Zinc Transporter Genes Are Upregulated in Gambian Women with Low Iron and Zinc Status 2017 · PE+MMN group · Pregnant women aged 18–45 years with singleton pregnancies under 20 weeks in rural Gambia | 60 mg | 300 mcg | 400 mcg | 4 mg | 2.8 mg | 184 days | 75 |